slides · global inventory
Solution
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 8,880
Current window 5,581-5,610
Pages 296
Rows per page 30
Slide type
5,581-5,610 of 8,880
05
The slide uses a hub-and-spoke diagram centered on 'Informed by Data, Powered by Technology' to connect various service offerings.Advantage Solutions | Investor Presentation Deck | 28 slides · Advantage Solutions
Pitch deck Investor relations Beat · Solution1 hit
08
The slide uses a process-oriented flow diagram to explain the mechanism of action for a combination therapy.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
09
The slide highlights the mechanism of action targeting multiple HBV transcripts.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
20
The slide uses a three-column layout to highlight key value propositions.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
22
Includes IC50 value and IFN-y fold increase data.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
23
The slide uses a three-column layout to explain the scientific basis and product profile.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
04
The slide uses a structured table-like layout to present scientific rationale (Background, Opportunity, Target Validation) followed by a summary box for the lead asset.Hillstream BioPharma | Investor Presentation Deck | 19 slides · Hillstream BioPharma
Pitch deck Investor relations Beat · Solution1 hit
08
The diagram illustrates the binding mechanism of the antibody to the cell surface receptors.Hillstream BioPharma | Investor Presentation Deck | 19 slides · Hillstream BioPharma
Pitch deck Investor relations Beat · Solution1 hit
09
Technical scientific slide showing protein structure and domain mapping.Hillstream BioPharma | Investor Presentation Deck | 19 slides · Hillstream BioPharma
Pitch deck Investor relations Beat · Solution1 hit
10
The slide uses a structural biology diagram to differentiate the binding mechanism of the company's asset from standard-of-care antibodies.Hillstream BioPharma | Investor Presentation Deck | 19 slides · Hillstream BioPharma
Pitch deck Investor relations Beat · Solution1 hit
11
Scientific illustration of a bispecific antibody binding to a HER2-HER3 dimer.Hillstream BioPharma | Investor Presentation Deck | 19 slides · Hillstream BioPharma
Pitch deck Investor relations Beat · Solution1 hit
12
The slide uses a visual representation of an ADC molecule to explain the components and the therapeutic mechanism.Hillstream BioPharma | Investor Presentation Deck | 19 slides · Hillstream BioPharma
Pitch deck Investor relations Beat · Solution1 hit
13
The slide explains the biological mechanism of the drug candidate HSB-3215.Hillstream BioPharma | Investor Presentation Deck | 19 slides · Hillstream BioPharma
Pitch deck Investor relations Beat · Solution1 hit
14
The slide uses a structural biology comparison between human and bovine antibody structures to highlight the unique 'knob' domain.Hillstream BioPharma | Investor Presentation Deck | 19 slides · Hillstream BioPharma
Pitch deck Investor relations Beat · Solution1 hit
08
The slide uses a grid-based layout to categorize technological capabilities.Lazard | Investor Presentation Deck | 45 slides · Lazard
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
25
The slide uses a circular diagram to represent the relationship between 'Solutions' and 'Applications' in capital markets.Lazard | Investor Presentation Deck | 45 slides · Lazard
Pitch deck Investor relations Beat · Financials1 hit
29
The slide uses a hub-and-spoke diagram centered on the vehicle to illustrate the integration of various technological subsystems.Lotus Cars | SPAC Presentation Deck | 60 slides · Lotus
Pitch deck Investment bank Beat · Solution1 hit
30
The slide highlights the integration of hardware (Qualcomm chips) and software (Hyper OS) with premium audio (KEF/Dolby Atmos).Lotus Cars | SPAC Presentation Deck | 60 slides · Lotus
Pitch deck Investment bank Beat · Solution1 hit
06
The slide uses a chromosome icon for the lead asset and a fast-forward icon for the pipeline.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The slide illustrates the biological interaction between THIO (telomere targeting) and CPIs (checkpoint inhibitors) to induce tumor cell death.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
The chart shows tumor volume over time, highlighting the superior performance of the THIO + Atezo combination compared to monotherapies and control.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
22
The slide uses two line charts to demonstrate tumor volume reduction and the effect of rechallenge.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
08
Includes a detailed biological pathway diagram and a Western blot image as evidence.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Solution1 hit
16
The slide uses a structural biology diagram to illustrate the mechanism of action (MOA) differentiation.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
17
Includes a biological pathway diagram, microscopy images, and an IC50 dose-response curve.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
19
The slide presents preclinical data supporting the efficacy of NXP900 in combination therapies.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
37
The slide uses a yellow callout box for the value proposition and three screenshots showing different partner implementations (Samsung, DRESSX, Puma).Snap Inc | Investor Presentation Deck | 50 slides · Snap Inc.
Pitch deck Investor relations 1 hit
39
The slide uses a hub-and-spoke style diagram to illustrate the integration of their AR tools.Snap Inc | Investor Presentation Deck | 50 slides · Snap Inc.
Pitch deck Investor relations 1 hit
18
The slide uses a horizontal process-like layout to map features to specific domains.VinFast | Investor Presentation Deck | 29 slides · VinFast
Pitch deck Investor relations Beat · Solution1 hit
19
The slide uses a central vehicle diagram with callouts to five key technology pillars.VinFast | Investor Presentation Deck | 29 slides · VinFast
Pitch deck Investor relations Beat · Solution1 hit